Results 1 to 10 of about 17,252 (224)

Pentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2. [PDF]

open access: goldPLoS Pathogens, 2016
The chemotherapeutic arsenal against human African trypanosomiasis, sleeping sickness, is limited and can cause severe, often fatal, side effects. One of the classic and most widely used drugs is pentamidine, an aromatic diamidine compound introduced in ...
Jie Song   +6 more
doaj   +13 more sources

Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis [PDF]

open access: goldCanadian Respiratory Journal, 1995
OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).
RA McIvor   +4 more
doaj   +2 more sources

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint [PDF]

open access: goldFrontiers in Immunology, 2023
Immunotherapy has emerged as an effective therapeutic approach to several cancer types. The reinvigoration of tumor-infiltrating lymphocyte-mediated immune responses via the blockade of immune checkpoint markers, such as program cell death-1 (PD-1) or ...
Tingxuan Gu   +27 more
doaj   +2 more sources

Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro

open access: goldDrug Design, Development and Therapy, 2021
Yi Wu,1 Zhong Zhang,2 Zuqiang Kou3 1Department of Pathogenic Biology, Shenyang Medical College, Shenyang City, Liaoning Province, 110004, People’s Republic of China; 2Department of Pathology, Shenyang Medical College, Shenyang City, Liaoning Province ...
Wu Y, Zhang Z, Kou Z
doaj   +3 more sources

Pentamidine dosage: a base/salt confusion. [PDF]

open access: goldPLoS Neglected Tropical Diseases, 2008
Pentamidine has a long history in the treatment of human African trypanosomiasis (HAT) and leishmaniasis. Early guidelines on the dosage of pentamidine were based on the base-moiety of the two different formulations available.
Thomas P C Dorlo, Piet A Kager
doaj   +3 more sources

Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis

open access: goldDrug Delivery, 2023
Topical drug delivery is preferable route over systemic delivery in case of Cutaneous leishmaniasis (CL). Among the available agents, amphotericin B (AmB) and pentamidine (PTM) showed promising result against CL.
Adnan Anjum   +11 more
doaj   +2 more sources

Insights from aquaporin structures into drug-resistant sleeping sickness [PDF]

open access: yeseLife
Trypanosoma brucei is the causal agent of African trypanosomiasis in humans and animals, the latter resulting in significant negative economic impacts in afflicted areas of the world.
Modestas Matusevicius   +22 more
doaj   +3 more sources

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

open access: yesPLoS Neglected Tropical Diseases, 2021
BackgroundHuman African trypanosomiasis (HAT or sleeping sickness) is caused by the parasite Trypanosoma brucei sspp. The disease has two stages, a haemolymphatic stage after the bite of an infected tsetse fly, followed by a central nervous system stage ...
Lisa Sanderson   +15 more
doaj   +1 more source

Combination Therapy with Ciprofloxacin and Pentamidine against Multidrug-Resistant Pseudomonas aeruginosa: Assessment of In Vitro and In Vivo Efficacy and the Role of Resistance–Nodulation–Division (RND) Efflux Pumps

open access: yesAntibiotics, 2023
The aim of this work was to (i) evaluate the efficacy of a combination treatment of pentamidine with ciprofloxacin against Galleria mellonella larvae infected with an MDR strain of P.
Megan Fletcher   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy